HOME > Scientists

Scientist Resources

Become a Member

The Journal of Nuclear Medicine

Molecular Imaging Journal

Position Statements

Legislative Issues & Priorities

Regulatory Issues & Priorities

Future Leaders Academy

Scientists

Welcome to the new scientist and researcher reference section. Your one-stop shop for the essential resources you need to advance your career.

Introducing the Virtual Poster Hall!


Explore the amazing research displayed at the SNMMI 2016 Annual Meeting.

SNMMI is continuing to highlight abstract presentations featured at the recent 2016 Annual Meeting with ePosters, a virtual online poster hall.

  • Includes the 650+ Scientific Abstract Oral Presentations and 1,000+ Scientific Abstract Posters
  • 24/7 online, anywhere access
  • CME, ACPE and VOICE credit (currently pending)

Order the Virtual Poster Hall.

Coding and Reimbursement

The most up-to-date and comprehensive source for nuclear medicine coding and reimbursement information on the web. Please note that ALL information and materials within the SNMMI Coding Corner are direct products of the SNMMI Coding and Reimbursement Working Group.

For Hospitals (APCs, IPPS) Find general coding and reimbursement information for hospitals.

For Private Practices (RBRVS) Find general coding and reimbursement information for professionals in private practices.

Coding and Reimbursement Q&A This easy to use feature contains over 100 questions and answers related to topics such as cardiac, endocrine, neurology, nuclear medicine-related drugs, oncology, PET, PET/CT, radiopharmaceuticals, and more!

Dose Optimization

In nuclear medicine and molecular imaging, small amounts of radioactive agents are administered to the patient to allow the physician to examine molecular processes within the body. These procedures are highly effective, safe and painless diagnostic tools that present physicians with a detailed view of what’s going on inside an individual’s body at the cellular level. For more than 60 years, these studies have been used to evaluate practically all systems within the body, including the heart and brain, as well as to image many types of cancer.

SNMMI has a large body of knowledge in dose optimization that is continually growing and developing. The dose optimization website presents a wide variety of resources, including SNMMI journal articles, educational offerings, media-related information, links to useful websites and more.

 

Preclinical Imaging

The goal of the SNMMI Best Practices in Preclinical Imaging Initiative is to provide guidelines based on the community experience in designing and conducting preclinical imaging experiments.

Available Resources Include:

Focusing on the Future of Molecular Imaging

SNMMI's Center for Molecular Imaging Innovation and Translation is an organizational component within the SNMMI that is dedicated to all aspects of molecular imaging in the detection and management of disease. The center is currently facilitating initiatives to bring molecular imaging discoveries from the lab to the patient and to advance "personalized" medicine.

Access resources.

The Clinical Trials Network’s mission is to advance the use of molecular imaging radiopharmaceuticals in clinical trials through standardization of chemistry and imaging methodology. This includes using imaging radiopharmaceuticals during the course of drug development, as well as bringing new agents to regulatory approval. Click here to learn more about the CTN’s Oncology and Neurology Scanner Validation programs, ongoing efforts to harmonize reconstruction parameters in oncology clinical trials, and other services that CTN offers to help scientists advance their research.

Educational Offerings

SNMMI educational programs are designed to meet the professional development needs of scientists involved in nuclear medicine and molecular imaging endeavors. 

Visit the SNMMI Learning Center.


Additional Resources

  • September 19, 2016 — PET Probe Images Breast Cancer’s Ability to Foil Treatment, Provides Therapy Guidance

    Cancer biologists know that inhibitor-mediated feedback loop changes (increased expression of a cell surface receptor in response to target inhibition) can result in breast cancer treatment failure and the need for additional therapy. A recent study by researchers at Massachusetts General Hospital in Boston and at Memorial Sloan Kettering in New York City shows that imaging of these cell surface receptor changes with PET probes specific to epidermal growth factor receptor 1 (EGFR) and human epidermal growth factor receptor 3 (HER3) directly addresses this unmet need in cancer therapy decision-making, while avoiding the need for repeated biopsies. The study is reported in the September issue of "The Journal of Nuclear Medicine."
    (Press Release)

  • September 13, 2016 — NAS Report Finds U.S. Supply of Critical Medical Isotope Vulnerable

    The National Academies of Sciences, Engineering, and Medicine have released a report on the state of molybdenum-99 (Mo-99) production, its utilization in medicine, and progress toward eliminating the use of highly enriched uranium (HEU) during production. The report says, “The committee judges that there is a substantial (>50 percent) likelihood of severe molybdenum-99/technetium-99m supply shortages after October 2016, lasting at least until current global suppliers complete their planned capacity expansions.”
    (Press Release)

  • September 12, 2016 — SNMMI-TS Leadership Academy—Applications Due Thursday

    Application deadlines are approaching for the SNMMI-TS Leadership Academy—a unique opportunity to increase leadership skills and opportunities through a 2-day course, fully funded by the Technologist Section.
    (SNMMI News)

  • September 7, 2016 — Call for Abstracts!

    Attention young professionals! Abstracts are now being accepted for the 2017 SNMMI Mid-Winter and ACNM Annual Meeting. Plus, learn how your abstract could get you selected to travel to China and participate in the Sino-American Exchange Program!
    (SNMMI News)

Spotlight

Guidelines

The practice guidelines help to identify those elements of the procedure that are most important in obtaining a high-quality examination, while simultaneously controlling costs. Use of standardized procedures will increase the applicability of clinical research among multiple institutions, in turn, increasing the value of research studies, particularly in the field of technology assessment. In the interest of creating strong, comprehensive documents, some guidelines were formally adopted by SNMMI in collaboration with other professional organizations.

View Guidelines.

Featured Resources

  • SNMMI Councils/Centers Internship Program Call for Applications

  • 2014 NCI-SNMMI Workshop on Targeted Radionuclide Therapy

    The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the National Cancer Institute (NCI) held a joint workshop—NCI-SNMMI Workshop on Targeted Radionuclide Therapy—on October 24-25, 2014, at the National Institutes of Health (NIH) in Bethesda, Md.

  • SNMMI Books

    Learn more about books published by the Society of Nuclear Medicine and Molecular Imaging and the Technologist Section.

  • Guidance

    Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.

  • Legislative Issues

    SNMMI monitors multiple federal legislative issues and provides resources including issue summaries, letters to Congress, and analysis.